目次

Chapter- 1: Introduction
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter- 2: Summary and Highlights
Table Summary : Global Market for Biologic Therapeutic Drugs, by Product Segment, Through 2025
Figure Summary : Global Market Shares of Biologic Therapeutic Drugs, by Product Segment, 2019

Chapter- 3: Market and Technology Background
Biopharmaceutical Industry Structure
Origins of Biotechnology
Involvement of Large Pharmaceutical Companies
Overview of Biologics
Biologics Manufacturing
Biopharmaceutical Manufacturing Process
FDA Regulation of Biologics

Chapter- 4: Impact of COVID-19 Pandemic
Introduction
Short-Term Impact
Long-Term Impact
Progression of COVID-19
Government Expenditures on COVID-19
Social Impact of COVID-19
Impact on Insurance Providers
Impact on Health Technology Assessment

Chapter- 5: Market Dynamics
Market Drivers
Market Restraints
Market Opportunities

Chapter- 6: Market Breakdown by Product Segment
Global Market for Biologic Therapeutic Drugs by Product Segment

Chapter- 7: Market Breakdown by Region
Global Market for Biologic Therapeutic Drugs by Region

Chapter- 8: Competitive Landscape
Porter's Five Forces Analysis

Chapter- 9: Company Profiles
AMGEN INC.
BAXTER
CHINA BIOLOGIC PRODUCTS INC.
CSL LTD.
DENDREON PHARMACEUTICALS LLC
ELI LILLY AND CO.
F. HOFFMANN-LA ROCHE LTD.
GLAXOSMITHKLINE PLC
GLYCOTOPE GMBH
GRIFOLS S.A.
JSC PHARMSTANDARD
KEDRION S.P.A.
NOVARTIS AG
OCTAPHARMA AG
RELIANCE LIFE SCIENCES
SANOFI
TEVA PHARMACEUTICAL INDUSTRIES LTD.